← Leaderboards
Thomas None Quertermous
Stanford University
$63,279,401
Attributed
$83,676,305
Total exposure
30
Grants
18
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $8.3M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$86,118,478 · 31
By mechanism
R01$55,559,939 · 20
U01$13,388,104 · 2
UM1$8,717,486 · 1
P01$3,233,268 · 4
T32$2,919,092 · 1
R33$1,552,131 · 1
Top collaborators
- Joseph C Wu33 shared
- Euan A Ashley8 shared
- Daniel Bernstein8 shared
- Jesse M Engreitz5 shared
- Eric E Schadt5 shared
- Russ Biagio Altman4 shared
- Colleen E Clancy4 shared
Most similar at Stanford University
Same institution · by research overlap
- Joseph C Wu$80,370,369
- Daniel Yuhang Li$292,119
- Elizabeth Susan Sattely$6,246,816
- Nazish Sayed$4,856,076
- Paul Po Sheng Cheng$2,095,794
Others in their field
Top investigators on “Molecular”
- David Heimbrook · Leidos Biomedical Research, Inc.$871,088,761
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Richard Webby · St. Jude Children'S Research Hospital$254,843,170
- Larry Arthur$238,531,074
- Gregory H Reaman · National Childhood Cancer Foundation$230,630,913
- Ralph Parchment · Leidos Biomedical Research, Inc.$193,231,914
Research focus
MolecularGenesPhenotypeCellsGeneticCardiovascular DiseasesMediatingIn VitroBlood VesselsGenome Wide Association StudyLinkCell TypeGene ExpressionVariantCoronary ArteriosclerosisAffectIn VivoSmooth Muscle MyocytesDisorder RiskGenetic TranscriptionComplexTissuesTranscription FactorPublic Health Relevance
Grant awards (129)
Identifying causal gene programs for vascular disease using high throughput CRISPR genomics$2,442,173
P01 · FY2025 · HL · contact PI
Stanford Center for Connecting DNA Variants to Function and Phenotype$1,844,885
UM1 · FY2025 · HG
Causal variant association mechanisms in TCF21 binding coronary disease loci$717,444
R01 · FY2025 · HL · contact PI
The SMAD3 signaling network in coronary artery disease risk$699,289
R01 · FY2025 · HL · contact PI
Gene regulatory networks controlling smooth muscle phenotype and vasculardisease risk$689,474
R01 · FY2025 · HL · contact PI
Molecular mechanisms of vascular calcification and their connection to coronary disease risk$569,364
R01 · FY2025 · HL · contact PI
Project 2: Smooth muscle cell programs for coronary artery disease$501,611
P01 · FY2025 · HL · contact PI
Scientific Core: CRISPRi mouse husbandry and AAV delivery$175,958
P01 · FY2025 · HL · contact PI
Administrative Core$113,526
P01 · FY2025 · HL · contact PI
Stanford Center for Connecting DNA Variants to Function and Phenotype$1,844,885
UM1 · FY2024 · HG
Gene regulatory networks controlling smooth muscle phenotype and vasculardisease risk$694,555
R01 · FY2024 · HL · contact PI
PDGFD regulates a transcriptional network to modulate smooth muscle cell transition and coronary artery disease risk$661,611
R01 · FY2024 · HL · contact PI
Identifying tobacco-genetic interactions through study of the aryl hydrocarbon receptor pathway.$654,259
R01 · FY2024 · HL · contact PI
Molecular mechanisms of vascular calcification and their connection to coronary disease risk$579,240
R01 · FY2024 · HL · contact PI
Causal variant association mechanisms in TCF21 binding coronary disease loci$553,417
R01 · FY2024 · HL · contact PI
Training in Myocardial Biology at Stanford$329,601
T32 · FY2024 · HL
Stanford Center for Connecting DNA Variants to Function and Phenotype$1,882,535
UM1 · FY2023 · HG
PDGFD regulates a transcriptional network to modulate smooth muscle cell transition and coronary artery disease risk$675,112
R01 · FY2023 · HL · contact PI
Identifying tobacco-genetic interactions through study of the aryl hydrocarbon receptor pathway.$667,612
R01 · FY2023 · HL · contact PI
Elucidating Genotype-Phenotype Relationship of Polygenic Dilated Cardiomyopathies$601,810
R01 · FY2023 · HL
Molecular mechanisms of vascular calcification and their connection to coronary disease risk$589,233
R01 · FY2023 · HL · contact PI
Causal variant association mechanisms in TCF21 binding coronary disease loci$584,533
R01 · FY2023 · HL · contact PI
Training in Myocardial Biology at Stanford$331,812
T32 · FY2023 · HL
Elucidating Genotype-Phenotype Relationship of Polygenic Dilated Cardiomyopathies$64,282
R01 · FY2023 · HL
Stanford Center for Connecting DNA Variants to Function and Phenotype$2,203,614
UM1 · FY2022 · HG
Genetic and Stem Cell Model of Cardiac Metabolic Disease$735,262
R01 · FY2022 · HL
Single Cell Sequencing of Human iPSC-CM Subtype Identity and Function$675,692
R01 · FY2022 · HL
PDGFD regulates a transcriptional network to modulate smooth muscle cell transition and coronary artery disease risk$675,112
R01 · FY2022 · HL · contact PI
Identifying tobacco-genetic interactions through study of the aryl hydrocarbon receptor pathway.$667,612
R01 · FY2022 · HL · contact PI
Molecular mechanisms of vascular calcification and their connection to coronary disease risk$622,834
R01 · FY2022 · HL · contact PI
Elucidating Genotype-Phenotype Relationship of Polygenic Dilated Cardiomyopathies$609,635
R01 · FY2022 · HL
Causal variant association mechanisms in TCF21 binding coronary disease loci$599,949
R01 · FY2022 · HL · contact PI
Training in Myocardial Biology at Stanford$492,589
T32 · FY2022 · HL
LncRNA Transcriptional Mechanisms of Coronary Artery Disease Risk$390,960
R01 · FY2022 · HL · contact PI
Elucidating Genotype-Phenotype Relationship of Polygenic Dilated Cardiomyopathies$128,566
R01 · FY2022 · HL
Stanford Center for Connecting DNA Variants to Function and Phenotype$941,567
UM1 · FY2021 · HG
Genetic and Stem Cell Model of Cardiac Metabolic Disease$786,697
R01 · FY2021 · HL
Single Cell Sequencing of Human iPSC-CM Subtype Identity and Function$684,695
R01 · FY2021 · HL
PDGFD regulates a transcriptional network to modulate smooth muscle cell transition and coronary artery disease risk$675,980
R01 · FY2021 · HL · contact PI
Identifying tobacco-genetic interactions through study of the aryl hydrocarbon receptor pathway.$668,481
R01 · FY2021 · HL · contact PI
Elucidating Genotype-Phenotype Relationship of Polygenic Dilated Cardiomyopathies$618,242
R01 · FY2021 · HL
Modeling Susceptibility to Chemotherapy-Induced Cardiotoxicity Using Human iPSCs$610,051
R01 · FY2021 · HL
Causal variant association mechanisms in TCF21 binding coronary disease loci$598,669
R01 · FY2021 · HL · contact PI
The SMAD3 signaling network in coronary artery disease risk$576,002
R01 · FY2021 · HL · contact PI
Modeling Tyrosine Kinase Inhibitor-Induced Vascular Dysfunction Using Human iPSCs$562,562
R01 · FY2021 · HL
Elucidating Genotype-Phenotype Relationship of Polygenic Dilated Cardiomyopathies: Administrative Supplement (INCLUDE)$501,316
R01 · FY2021 · HL
Modeling Anthracycline-Induced Cognitive Impairment Using iPSC-Derived Brain-On-Chips$393,607
R01 · FY2021 · HL
LncRNA Transcriptional Mechanisms of Coronary Artery Disease Risk$390,936
R01 · FY2021 · HL · contact PI
Elucidating Genotype-Phenotype Relationship of Polygenic Dilated Cardiomyopathies$156,852
R01 · FY2021 · HL
Elucidating Genotype-Phenotype Relationship of Polygenic Dilated Cardiomyopathies$121,848
R01 · FY2021 · HL
Genetic and Stem Cell Model of Cardiac Metabolic Disease$750,912
R01 · FY2020 · HL
Single Cell Sequencing of Human iPSC-CM Subtype Identity and Function$692,649
R01 · FY2020 · HL
Elucidating Genotype-Phenotype Relationship of Polygenic Dilated Cardiomyopathies$625,285
R01 · FY2020 · HL
Causal variant association mechanisms in TCF21 binding coronary disease loci$618,063
R01 · FY2020 · HL · contact PI
Modeling Tyrosine Kinase Inhibitor-Induced Vascular Dysfunction Using Human iPSCs$580,336
R01 · FY2020 · HL
The SMAD3 signaling network in coronary artery disease risk$576,002
R01 · FY2020 · HL · contact PI
Modeling Tyrosine Kinase Inhibitor-Induced Vascular Dysfunction Using Human iPSCs$575,237
R01 · FY2020 · HL
Modeling Susceptibility to Chemotherapy-Induced Cardiotoxicity Using Human iPSCs$537,363
R01 · FY2020 · HL
LncRNA Transcriptional Mechanisms of Coronary Artery Disease Risk$390,952
R01 · FY2020 · HL · contact PI
Training in Myocardial Biology at Stanford (TIMBS)$215,679
T32 · FY2020 · HL
Modeling Susceptibility to Chemotherapy-Induced Cardiotoxicity Using Human iPSCs$83,587
R01 · FY2020 · HL
Genetic and Stem Cell Model of Cardiac Metabolic Disease$53,214
R01 · FY2020 · HL
Genetic and Stem Cell Model of Cardiac Metabolic Disease$758,244
R01 · FY2019 · HL
Mechanism of the Coronary Heart Disease Association at Chromosome 6q23.2$705,979
R01 · FY2019 · HL · contact PI
Single Cell Sequencing of Human iPSC-CM Subtype Identity and Function$701,120
R01 · FY2019 · HL
Causal variant association mechanisms in TCF21 binding coronary disease loci$618,063
R01 · FY2019 · HL · contact PI
Modeling Tyrosine Kinase Inhibitor-Induced Vascular Dysfunction Using Human iPSCs$587,417
R01 · FY2019 · HL
The SMAD3 signaling network in coronary artery disease risk$576,002
R01 · FY2019 · HL · contact PI
Modeling Susceptibility to Chemotherapy-Induced Cardiotoxicity Using Human iPSCs$547,608
R01 · FY2019 · HL
Molecular Mechanisms of Insulin Resistance Associated Loci$537,659
R01 · FY2019 · DK · contact PI
Training in Myocardial Biology at Stanford (TIMBS)$449,146
T32 · FY2019 · HL
LncRNA Transcriptional Mechanisms of Coronary Artery Disease Risk$405,077
R01 · FY2019 · HL · contact PI
A Systems Biology Approach to Study Cardiac Arrhythmias: iPS Cells and In Silico Modeling$730,325
R01 · FY2018 · HL
Mechanism of the Coronary Heart Disease Association at Chromosome 6q23.2$699,078
R01 · FY2018 · HL · contact PI
Causal variant association mechanisms in TCF21 binding coronary disease loci$618,063
R01 · FY2018 · HL · contact PI
Modeling Tyrosine Kinase Inhibitor-Induced Vascular Dysfunction Using Human iPSCs$596,600
R01 · FY2018 · HL
The SMAD3 signaling network in coronary artery disease risk$576,002
R01 · FY2018 · HL · contact PI
Modeling Susceptibility to Chemotherapy-Induced Cardiotoxicity Using Human iPSCs$555,144
R01 · FY2018 · HL
Molecular Mechanisms of Insulin Resistance Associated Loci$536,612
R01 · FY2018 · DK · contact PI
Identification of causal coronary heart disease variation in smooth muscle cells$517,377
R33 · FY2018 · HL · contact PI
Training in Myocardial Biology at Stanford (TIMBS)$282,480
T32 · FY2018 · HL
A Systems Biology Approach to Study Cardiac Arrhythmias: iPS Cells and In Silico Modeling$746,125
R01 · FY2017 · HL
Mechanism of the Coronary Heart Disease Association at Chromosome 6q23.2$692,621
R01 · FY2017 · HL · contact PI
Causal variant association mechanisms in TCF21 binding coronary disease loci$618,063
R01 · FY2017 · HL · contact PI
Molecular Mechanisms of Insulin Resistance Associated Loci$546,913
R01 · FY2017 · DK · contact PI
Identification of causal coronary heart disease variation in smooth muscle cells$517,377
R33 · FY2017 · HL · contact PI
Training in Myocardial Biology at Stanford (TIMBS)$405,860
T32 · FY2017 · HL
A Systems Biology Approach to Study Cardiac Arrhythmias: iPS Cells and In Silico Modeling$758,646
R01 · FY2016 · HL
Mechanism of the Coronary Heart Disease Association at Chromosome 6q23.2$686,628
R01 · FY2016 · HL · contact PI
Molecular Mechanisms of Insulin Resistance Associated Loci$529,300
R01 · FY2016 · DK · contact PI
Identification of causal coronary heart disease variation in smooth muscle cells$517,377
R33 · FY2016 · HL · contact PI
Training in Myocardial Biology at Stanford (TIMBS)$411,925
T32 · FY2016 · HL
Identifying the gene networks of insulin resistance: the GENESIPS study$2,272,407
U01 · FY2015 · HL · contact PI
A Systems Biology Approach to Study Cardiac Arrhythmias: iPS Cells and In Silico Modeling$786,927
R01 · FY2015 · HL
Mechanism of the coronary heart disease association at chromosome 6q23.2$677,568
R01 · FY2015 · HL · contact PI
Identification of causal coronary heart disease variation in smooth muscle cells$213,264
R21 · FY2015 · HL · contact PI
Identifying the gene networks of insulin resistance: the GENESIPS study$2,267,492
U01 · FY2014 · HL · contact PI
Mechanism of the coronary heart disease association at chromosome 6q23.2$661,712
R01 · FY2014 · HL · contact PI
Identification of causal coronary heart disease variation in smooth muscle cells$220,688
R21 · FY2014 · HL · contact PI
Identifying the gene networks of insulin resistance: the GENESIPS study$2,214,717
U01 · FY2013 · HL · contact PI
Mechanism of the coronary heart disease association at chromosome 6q23.2$649,375
R01 · FY2013 · HL · contact PI
Identification and study of the vascular disease gene at 9p21.3$588,465
R01 · FY2013 · HL · contact PI
Identifying the gene networks of insulin resistance: the GENESIPS study$1,215,917
U01 · FY2012 · HL · contact PI
Mechanism of the coronary heart disease association at chromosome 6q23.2$670,804
R01 · FY2012 · HL · contact PI
Identification and study of the vascular disease gene at 9p21.3$615,620
R01 · FY2012 · HL · contact PI
Identifying the gene networks of insulin resistance: the GENESIPS study$784,798
U01 · FY2011 · HL · contact PI
Mechanism of the coronary heart disease association at chromosome 6q23.2$644,514
R01 · FY2011 · HL · contact PI
Identification and study of the vascular disease gene at 9p21.3$619,394
R01 · FY2011 · HL · contact PI
Identification and study of the vascular disease gene at 9p21.3$618,944
R01 · FY2010 · HL · contact PI
Whole Genome Association for Early Coronary Artery Disease and Related Phenotypes$701,042
R01 · FY2008 · HL · contact PI
Endothelial Basis of the Apelin-APJ Pathway$372,259
R01 · FY2008 · HL · contact PI
Whole Genome Association for Early Coronary Artery Disease and Related Phenotypes$1,746,902
R01 · FY2007 · HL · contact PI
Endothelial Basis of the Apelin-APJ Pathway$372,183
R01 · FY2007 · HL · contact PI
Whole Genome Association Early Coronary Artery Disease$2,153,713
R01 · FY2006 · HL · contact PI
Endothelial Basis of the Apelin-APJ Pathway$383,228
R01 · FY2006 · HL · contact PI
Endothelial Basis of the Apelin-APJ Pathway$392,975
R01 · FY2005 · HL
GENETIC DETERMINANTS OF HUMAN HYPERTENSION$1,153,572
U01 · FY2004 · HL
Endothelial Intracellular Signaling in Angiogenesis$277,653
R01 · FY2004 · HL
GENETIC DETERMINANTS OF HUMAN HYPERTENSION$881,825
U01 · FY2003 · HL
Endothelial Intracellular Signaling in Angiogenesis$277,567
R01 · FY2003 · HL
GENETIC DETERMINANTS OF HUMAN HYPERTENSION$1,093,036
U01 · FY2002 · HL
Endothelial Intracellular Signaling in Angiogenesis$277,486
R01 · FY2002 · HL
Initial Characterization of Pig Hemangioblasts$157,264
R21 · FY2002 · HL
GENETIC DETERMINANTS OF HUMAN HYPERTENSION$1,064,085
U01 · FY2001 · HL
MOLECULAR BASIS OF ENDOTHELIAL CELL DIFFERENTATION$275,240
R01 · FY2001 · HL
Endothelial Intracellular Signaling in Angiogenesis$263,156
R01 · FY2001 · HL
Initial Characterization of Pig Hemangioblasts$157,242
R21 · FY2001 · HL
GENETIC DETERMINANTS OF HUMAN HYPERTENSION$440,255
U01 · FY2000 · HL
MOLECULAR BASIS OF ENDOTHELIAL CELL DIFFERENTATION$269,528
R01 · FY2000 · HL